MMP9 and renal cell carcinoma: For example, as a member of the serum amyloid A family of apolipoproteins, SAA1 can increase the invasive capacity of tumor cells in RCC by inducing MMP-9 expression (73), which make it serve as a biomarker for the diagnosis and prognosis of advanced and metastatic renal cell carcinoma.